MARKET

HOTH

HOTH

Hoth Therapeutics Inc
NASDAQ
0.8082
+0.0381
+4.95%
After Hours: 0.8000 -0.0082 -1.01% 18:09 02/06 EST
OPEN
0.7800
PREV CLOSE
0.7701
HIGH
0.8150
LOW
0.7800
VOLUME
135.75K
TURNOVER
--
52 WEEK HIGH
2.115
52 WEEK LOW
0.6554
MARKET CAP
12.54M
P/E (TTM)
-0.7598
1D
5D
1M
3M
1Y
5Y
1D
Hoth Therapeutics confirms it holds no cryptocurrency assets
TipRanks · 3d ago
Hoth Therapeutics Confirms It Holds No Cryptocurrency Assets
Reuters · 3d ago
HOTH THERAPEUTICS ADDRESSES MARKET RUMOR, HOTH HOLDS NO CRYPTO CURRENCY ASSETS
Reuters · 3d ago
Weekly Report: what happened at HOTH last week (0126-0130)?
Weekly Report · 02/02 09:25
Weekly Report: what happened at HOTH last week (0119-0123)?
Weekly Report · 01/26 09:25
Hoth Therapeutics Early Cancer Trial Succeeds With 100% Patient Response, Cuts Disease Severity By Half
Benzinga · 01/22 17:47
Hoth Therapeutics’ HT-001 shows 100% response in EFGR-treated cancer patients
TipRanks · 01/22 13:27
Hoth Therapeutics Announced Interim Results From The Open-Label Pharmacokinetic Cohort Of Its Ongoing CLEER-001 Clinical Trial Evaluating HT-001 In Cancer Patients Receiving EGFR Inhibitor Therapy; Primary Endpoint ARIGA Improved By ~50% From Baseline By Week 6, With All Evaluable Patients Reaching Low-severity Disease; Additional Endpoints Demonstrated ~34% Improvement In Oncology Toxicity And ~37% Reduction In Patient-Reported Pruritus
Benzinga · 01/22 13:16
More
About HOTH
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs. The Company is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT), and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The Company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004), and a treatment for obesity, and obesity-related diseases and conditions (HT-VA).

Webull offers Hoth Therapeutics Inc stock information, including NASDAQ: HOTH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HOTH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HOTH stock methods without spending real money on the virtual paper trading platform.